Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells

Takuji Mori, Joseph Kim, Tomoki Yamano, Hiroya Takeuchi, Sharon Huang, Naoyuki Umetani, Kazuo Koyanagi, Dave S B Hoon

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Histone deacetylation and DNA methylation establish epigenetic modifications, which through chromatin remodeling may result in gene silencing. We hypothesized that chemokine receptors C-C chemokine receptor 7 (CCR7) and C-X-C chemokine receptor 4 (CXCR4) on melanoma cells undergo epigenetic regulation. We investigated whether a histone deacetylase inhibitor and a demethylating agent influence CCR7 and CXCR4 expression on melanoma cells. Initially, microarray analysis was done to screen changes in chemokine receptor expression on melanoma cells after treatment with trichostatin A (TSA) and 5-Aza-2-deoxycytidine (5-Aza). CCR7 and CXCR4 mRNA expression were uniformly altered and selected for further investigation. Quantitative real-time reverse transcription-PCR assay, immunohistochemistry, and Western blot analysis were used to assess changes in mRNA and protein expression induced by TSA and 5-Aza in melanoma lines. Cell migration assays were conducted to assess the effects of altered CCR7 and CXCR4 expression on cell function. Treatment with TSA or 5-Aza increased gene expression of both CCR7 and CXCR4 in melanoma lines. TSA was the strongest enhancer. With combined treatment, CCR7 and CXCR4 mRNA expression was also up-regulated. Immunohistochemistry after combined treatment showed enhanced staining of both CCR7 and CXCR4 compared with control cells. Melanoma cell migration in TSA and 5-Aza-treated cells was 7-and 2-fold higher than control cells for CCR7 and CXCR4, respectively. In summary, a histone deacetylase inhibitor and a demethylating agent up-regulated CCR7 and CXCR4 expression on melanoma cells. This increase in chemokine receptor expression correlated with functional activity. Most importantly, we have identified an epigenetic mechanism that may endogenously regulate chemokine receptor expression on melanoma cells.

Original languageEnglish
Pages (from-to)1800-1807
Number of pages8
JournalCancer Research
Volume65
Issue number5
DOIs
Publication statusPublished - 2005 Mar 1
Externally publishedYes

Fingerprint

CXC Chemokines
CC Chemokines
Chemokine Receptors
Epigenomics
Melanoma
Up-Regulation
trichostatin A
Histone Deacetylase Inhibitors
decitabine
Messenger RNA
Immunohistochemistry
Cell Migration Assays

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mori, T., Kim, J., Yamano, T., Takeuchi, H., Huang, S., Umetani, N., ... Hoon, D. S. B. (2005). Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. Cancer Research, 65(5), 1800-1807. https://doi.org/10.1158/0008-5472.CAN-04-3531

Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. / Mori, Takuji; Kim, Joseph; Yamano, Tomoki; Takeuchi, Hiroya; Huang, Sharon; Umetani, Naoyuki; Koyanagi, Kazuo; Hoon, Dave S B.

In: Cancer Research, Vol. 65, No. 5, 01.03.2005, p. 1800-1807.

Research output: Contribution to journalArticle

Mori, T, Kim, J, Yamano, T, Takeuchi, H, Huang, S, Umetani, N, Koyanagi, K & Hoon, DSB 2005, 'Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells', Cancer Research, vol. 65, no. 5, pp. 1800-1807. https://doi.org/10.1158/0008-5472.CAN-04-3531
Mori, Takuji ; Kim, Joseph ; Yamano, Tomoki ; Takeuchi, Hiroya ; Huang, Sharon ; Umetani, Naoyuki ; Koyanagi, Kazuo ; Hoon, Dave S B. / Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. In: Cancer Research. 2005 ; Vol. 65, No. 5. pp. 1800-1807.
@article{99b314974fd44abb8c431b66a3e97923,
title = "Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells",
abstract = "Histone deacetylation and DNA methylation establish epigenetic modifications, which through chromatin remodeling may result in gene silencing. We hypothesized that chemokine receptors C-C chemokine receptor 7 (CCR7) and C-X-C chemokine receptor 4 (CXCR4) on melanoma cells undergo epigenetic regulation. We investigated whether a histone deacetylase inhibitor and a demethylating agent influence CCR7 and CXCR4 expression on melanoma cells. Initially, microarray analysis was done to screen changes in chemokine receptor expression on melanoma cells after treatment with trichostatin A (TSA) and 5-Aza-2-deoxycytidine (5-Aza). CCR7 and CXCR4 mRNA expression were uniformly altered and selected for further investigation. Quantitative real-time reverse transcription-PCR assay, immunohistochemistry, and Western blot analysis were used to assess changes in mRNA and protein expression induced by TSA and 5-Aza in melanoma lines. Cell migration assays were conducted to assess the effects of altered CCR7 and CXCR4 expression on cell function. Treatment with TSA or 5-Aza increased gene expression of both CCR7 and CXCR4 in melanoma lines. TSA was the strongest enhancer. With combined treatment, CCR7 and CXCR4 mRNA expression was also up-regulated. Immunohistochemistry after combined treatment showed enhanced staining of both CCR7 and CXCR4 compared with control cells. Melanoma cell migration in TSA and 5-Aza-treated cells was 7-and 2-fold higher than control cells for CCR7 and CXCR4, respectively. In summary, a histone deacetylase inhibitor and a demethylating agent up-regulated CCR7 and CXCR4 expression on melanoma cells. This increase in chemokine receptor expression correlated with functional activity. Most importantly, we have identified an epigenetic mechanism that may endogenously regulate chemokine receptor expression on melanoma cells.",
author = "Takuji Mori and Joseph Kim and Tomoki Yamano and Hiroya Takeuchi and Sharon Huang and Naoyuki Umetani and Kazuo Koyanagi and Hoon, {Dave S B}",
year = "2005",
month = "3",
day = "1",
doi = "10.1158/0008-5472.CAN-04-3531",
language = "English",
volume = "65",
pages = "1800--1807",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells

AU - Mori, Takuji

AU - Kim, Joseph

AU - Yamano, Tomoki

AU - Takeuchi, Hiroya

AU - Huang, Sharon

AU - Umetani, Naoyuki

AU - Koyanagi, Kazuo

AU - Hoon, Dave S B

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Histone deacetylation and DNA methylation establish epigenetic modifications, which through chromatin remodeling may result in gene silencing. We hypothesized that chemokine receptors C-C chemokine receptor 7 (CCR7) and C-X-C chemokine receptor 4 (CXCR4) on melanoma cells undergo epigenetic regulation. We investigated whether a histone deacetylase inhibitor and a demethylating agent influence CCR7 and CXCR4 expression on melanoma cells. Initially, microarray analysis was done to screen changes in chemokine receptor expression on melanoma cells after treatment with trichostatin A (TSA) and 5-Aza-2-deoxycytidine (5-Aza). CCR7 and CXCR4 mRNA expression were uniformly altered and selected for further investigation. Quantitative real-time reverse transcription-PCR assay, immunohistochemistry, and Western blot analysis were used to assess changes in mRNA and protein expression induced by TSA and 5-Aza in melanoma lines. Cell migration assays were conducted to assess the effects of altered CCR7 and CXCR4 expression on cell function. Treatment with TSA or 5-Aza increased gene expression of both CCR7 and CXCR4 in melanoma lines. TSA was the strongest enhancer. With combined treatment, CCR7 and CXCR4 mRNA expression was also up-regulated. Immunohistochemistry after combined treatment showed enhanced staining of both CCR7 and CXCR4 compared with control cells. Melanoma cell migration in TSA and 5-Aza-treated cells was 7-and 2-fold higher than control cells for CCR7 and CXCR4, respectively. In summary, a histone deacetylase inhibitor and a demethylating agent up-regulated CCR7 and CXCR4 expression on melanoma cells. This increase in chemokine receptor expression correlated with functional activity. Most importantly, we have identified an epigenetic mechanism that may endogenously regulate chemokine receptor expression on melanoma cells.

AB - Histone deacetylation and DNA methylation establish epigenetic modifications, which through chromatin remodeling may result in gene silencing. We hypothesized that chemokine receptors C-C chemokine receptor 7 (CCR7) and C-X-C chemokine receptor 4 (CXCR4) on melanoma cells undergo epigenetic regulation. We investigated whether a histone deacetylase inhibitor and a demethylating agent influence CCR7 and CXCR4 expression on melanoma cells. Initially, microarray analysis was done to screen changes in chemokine receptor expression on melanoma cells after treatment with trichostatin A (TSA) and 5-Aza-2-deoxycytidine (5-Aza). CCR7 and CXCR4 mRNA expression were uniformly altered and selected for further investigation. Quantitative real-time reverse transcription-PCR assay, immunohistochemistry, and Western blot analysis were used to assess changes in mRNA and protein expression induced by TSA and 5-Aza in melanoma lines. Cell migration assays were conducted to assess the effects of altered CCR7 and CXCR4 expression on cell function. Treatment with TSA or 5-Aza increased gene expression of both CCR7 and CXCR4 in melanoma lines. TSA was the strongest enhancer. With combined treatment, CCR7 and CXCR4 mRNA expression was also up-regulated. Immunohistochemistry after combined treatment showed enhanced staining of both CCR7 and CXCR4 compared with control cells. Melanoma cell migration in TSA and 5-Aza-treated cells was 7-and 2-fold higher than control cells for CCR7 and CXCR4, respectively. In summary, a histone deacetylase inhibitor and a demethylating agent up-regulated CCR7 and CXCR4 expression on melanoma cells. This increase in chemokine receptor expression correlated with functional activity. Most importantly, we have identified an epigenetic mechanism that may endogenously regulate chemokine receptor expression on melanoma cells.

UR - http://www.scopus.com/inward/record.url?scp=16444373352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16444373352&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-3531

DO - 10.1158/0008-5472.CAN-04-3531

M3 - Article

C2 - 15753377

AN - SCOPUS:16444373352

VL - 65

SP - 1800

EP - 1807

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 5

ER -